Stage IB Pancreatic Cancer Completed Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0034490 (Stage IB Pancreatic Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01959672Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic CancerTreatment
NCT00305877Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryTreatment
NCT00609336Combination Chemotherapy, Intensity-Modulated Radiation Therapy, and Surgery in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryTreatment